Lumentum's Record Quarter Masks a Supply Problem That Could Define Its Future

Lumentum posts record revenue of $808.4M and 32.2% margins, but shares fall 7% as profit-taking follows a 1,300% yearly surge. Supply constraints loom.

The optics specialist delivered numbers that would make most chief executives blush, yet the market response was anything but celebratory. Lumentum shares slid more than 7 percent on Wednesday to €795.30, a move that says less about the company's performance and more about the staggering run-up that preceded it. The stock has surged roughly 1,300 percent over the past twelve months, hitting a fresh 52-week high just a day before the earnings release. Profit-taking, it seems, was inevitable.

Margins That Tell a Story of Scale

Revenue for the third fiscal quarter hit a record $808.4 million, representing a 90 percent jump from the prior-year period. The system segment led the charge with 121 percent year-over-year growth, fueled by insatiable demand from cloud transceivers. The components division chipped in $533.3 million. But the headline number that caught Wall Street's attention was the adjusted operating margin: 32.2 percent, a 2,100 basis point improvement from a year ago and a 700 basis point leap from the previous quarter. Adjusted earnings per share came in at $2.37, comfortably ahead of analyst consensus.

The margin expansion underscores how quickly Lumentum is benefiting from operating leverage as hyperscalers pour capital into AI infrastructure. Yet the company's own guidance suggests the best may still be ahead. For the fourth quarter ending in June, management projects revenue between $960 million and just over $1 billion, with operating margins climbing as high as 36 percent. Adjusted EPS is expected to land between $2.85 and $3.05, both figures above what analysts had penciled in.

A Capacity Crunch That Can't Be Ignored

For all the financial fireworks, Lumentum faces a challenge that could cap its growth trajectory. Demand for key products — including EML lasers and pump lasers — currently outstrips supply by more than 30 percent. The company acknowledges the bottleneck, and the solution is a new indium phosphide manufacturing facility in Greensboro, North Carolina. Production is slated to begin in early 2028, a timeline that raises a pressing question: can Lumentum bridge the gap before competitors close in?

The company has not been idle on the balance sheet front. Cash and equivalents swelled by roughly $2 billion to $3.17 billion, largely driven by a preferred stock issuance. Management also restructured the debt profile, converting nearly $475 million in convertible bonds into common equity, which will reduce future interest expenses.

Analysts See Room to Run

Stifel and Loop Capital have raised their price targets to $1,100 and $1,400 respectively, maintaining buy ratings. Both firms cite strong order visibility and Lumentum's central role in hyperscaler capital expenditure plans. The company's recent addition to the S&P 500 this spring adds another layer of institutional credibility.

The tension between record financial performance and a supply chain that cannot keep pace will define Lumentum's narrative over the next two years. The new Greensboro plant offers a long-term fix, but whether it arrives in time to fend off emerging competition remains the operative question for investors watching this AI infrastructure play.